Maternal mental health remains one of the most underdiagnosed complications of pregnancy, with long-term implications for maternal morbidity and neonatal developmental outcomes. Untreated perinatal mood disorders are associated with increased rates of preterm birth, low birth weight, and impaired maternal-infant bonding. Despite clinical recommendations, screening across the United States and global healthcare systems remains fragmented, often relying on clinician intuition rather than validated psychometric scales. This research is highly relevant to the AAMS Maternal & Reproductive Health Conference as it provides robust empirical evidence supporting the transition toward integrated behavioral health in obstetric settings. By quantifying the gap between screening and diagnosis, this study offers a roadmap for clinicians and policymakers to implement more effective intervention strategies. Addressing these disparities is crucial for reducing the global burden of maternal mortality, of which suicide and substance use related to untreated mental illness are significant contributors.
This study aims to evaluate the efficacy of integrated longitudinal mental health screening in identifying perinatal mood disorders and to quantify the predictive relationship between antenatal distress scores and postpartum clinical outcomes.
A prospective cohort study was conducted involving 840 pregnant individuals recruited from tertiary obstetric clinics between 2021 and 2023. Participants underwent standardized screening at three intervals: First Trimester (T1), Third Trimester (T2), and 6-weeks Postpartum (P1). Screening instruments included the EPDS for depressive symptoms (cutoff ≥10) and the GAD-7 for anxiety (cutoff ≥8). Sociodemographic data, obstetric history, and psychosocial stressors were recorded via electronic health records. Logistic regression models were utilized to determine the Odds Ratio (OR) of postpartum depression based on antenatal scores, adjusting for age, parity, and socioeconomic status. Validity of the screening tools was assessed via clinical diagnostic interviews (SCID-5) in a subset of 150 high-scoring participants to determine positive predictive values (PPVs). Data analysis was performed using SPSS v.27, with significance set at p < 0.05.
Of the 840 participants, 18.2% (n=153) screened positive for significant distress at T1, and 21.5% (n=181) at P1. A significant correlation was found between T1 EPDS scores ≥12 and the development of postpartum depression (OR 4.3; 95% CI, 2.8–6.5; p < 0.001). Antenatal anxiety, measured by GAD-7, was present in 14.8% of the cohort and served as a stronger predictor for emergency obstetric interventions than depression alone (OR 2.1; p = 0.014). Notably, 38% of those who screened positive in the postpartum period had no prior history of mental health disorders, emphasizing the necessity of universal screening. The Positive Predictive Value (PPV) of the EPDS in this cohort was 76.4% when compared against SCID-5 diagnostic criteria. Among patients who received immediate psychiatric referral following a positive screen, 62% showed a clinical reduction in symptom severity by the 6-month follow-up, compared to only 29% in the delayed-referral group (p < 0.005).
The implementation of standardized, multi-stage screening demonstrates that antenatal mental health status is a potent predictor of postpartum morbidity. Our findings suggest that current episodic screening models may miss up to 22.4% of late-onset postpartum mood disorders. Integrating GAD-7 alongside the EPDS is essential, as isolated anxiety frequently precedes depressive symptomology. The results advocate for a mandatory 'triple-screen' approach (first trimester, third trimester, and six-weeks postpartum) to ensure early detection. Furthermore, the correlation between high EPDS scores and subsequent obstetric complications necessitates a multidisciplinary approach where mental health is prioritized as a core component of obstetric safety. Standardized protocols not only improve detection rates but, when linked to immediate referral pathways, significantly mitigate the severity of PMADs. Future policy should focus on reimbursement models that support this integrated care framework.